Human glioblastoma cell lines: Levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein

Citation
L. Maletinska et al., Human glioblastoma cell lines: Levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein, CANCER RES, 60(8), 2000, pp. 2300-2303
Citations number
36
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
60
Issue
8
Year of publication
2000
Pages
2300 - 2303
Database
ISI
SICI code
0008-5472(20000415)60:8<2300:HGCLLO>2.0.ZU;2-V
Abstract
The status of the low-density lipoprotein (LDL) receptor and LDL receptor-r elated protein (LRP) in seven human glioma cell lines was evaluated to exte nd our knowledge of human glioblastoma multiforme tumor metabolism for futu re drug design. Cell lines SF-767, SF-763, A-172, U-87 MG, U-251 MG, U343 M G, and SF-539 were used. Binding of I-125-labeled LDL to these cells at 4 d egrees C was carried out to determine the number of LDL receptors on cells and the affinity of LDL for these receptors, The content of LRP was measure d by immunoblotting. The presence of specific saturable LDL receptors was p roven in six of the cell lines investigated. SF-767 cells revealed high-aff inity LDL binding (equilibrium dissociation constant, K-d = 7 nM) and maxim um binding capacity approximating 300,000 receptors/cell, Most of the remai ning cell lines had relatively lower affinity (K-d = 38-62 nM) but also had very high numbers of receptors (128,000-950,000/cell). All cell lines exhi bited LRP, but the expression was variable. The cell lines SF-539, U-87 MG, and U-343 MG were particularly rich in this protein. The data suggest that glioblastoma cells have high numbers of LDL receptors; however, there is c onsiderable variation in binding affinity. Overall, this finding suggests t hat LDL receptors on glioblastoma cells could potentially be useful for tar geting antitumor agents. LRP, a multifunctional receptor expressed on gliob lastoma cells, also has the possibility for serving as a therapeutic target .